SERUM URIDINE LEVELS IN PATIENTS RECEIVING N-(PHOSPHONACETYL)-L-ASPARTATE

被引：0
作者：
KARLE, JM [1 ]
ANDERSON, LW [1 ]
ERLICHMAN, C [1 ]
CYSYK, RL [1 ]
机构：
[1] NCI,CLIN PHARMACOL BRANCH,BETHESDA,MD 20205
来源：
CANCER RESEARCH | 1980年 / 40卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2938 / 2940
页数：3
相关论文
共 50 条
[41]   A TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (FU) IN PATIENTS (PTS.) WITH METASTATIC COLORECTAL-CANCER [J].
CAMACHO, FJ ;
MUGGIA, FM ;
KAPLAN, BH .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR) :457-457
[42]   PHASE-I TRIAL OF N-(PHOSPHONACETYL)-L-ASPARTATE, METHOTREXATE, AND 5-FLUOROURACIL WITH LEUCOVORIN RESCUE IN PATIENTS WITH ADVANCED CANCER [J].
KEMENY, N ;
SCHNEIDER, A ;
MARTIN, DS ;
COLOFIORE, J ;
SAWYER, RC ;
DERBY, S ;
SALVIA, B .
CANCER RESEARCH, 1989, 49 (16) :4636-4639
[43]   STRUCTURE OF AMPLIFIED DNA IN DIFFERENT SYRIAN-HAMSTER CELL-LINES RESISTANT TO N-(PHOSPHONACETYL)-L-ASPARTATE [J].
ARDESHIR, F ;
GIULOTTO, E ;
ZIEG, J ;
BRISON, O ;
LIAO, WSL ;
STARK, GR .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (11) :2076-2088
[44]   COMPARATIVE PHYSIOLOGICAL DISPOSITION OF N-(PHOSPHONACETYL)-L-ASPARTATE IN SEVERAL ANIMAL SPECIES AFTER INTRAVENOUS AND ORAL-ADMINISTRATION [J].
CHADWICK, M ;
SILVEIRA, DM ;
MACGREGOR, JA ;
BRANFMAN, AR ;
LISS, RH ;
YESAIR, DW .
CANCER RESEARCH, 1982, 42 (02) :627-632
[45]   MODULATION OF HUMAN OVARIAN TUMOR-CELL SENSITIVITY TO N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) BY LIPOSOME DRUG CARRIERS [J].
SHARMA, A ;
STRAUBINGER, NL ;
STRAUBINGER, RM .
PHARMACEUTICAL RESEARCH, 1993, 10 (10) :1434-1441
[46]   PHARMACOKINETICS OF N-(PHOSPHONACETYL)-L-ASPARTATE (PALA) AND 5-FLUOROURACIL (5-FU) COMBINATION IN BEAGLE DOGS [J].
MILLER, AA ;
MOORE, EC ;
LOO, TL .
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR) :245-245
[47]   PLASMA URIDINE CHANGES IN CANCER-PATIENTS TREATED WITH THE COMBINATION OF DIPYRIDAMOLE AND N-PHOSPHONACETYL-L-ASPARTATE [J].
CHAN, TCK ;
MARKMAN, M ;
CLEARY, S ;
HOWELL, SB .
CANCER RESEARCH, 1986, 46 (06) :3168-3172
[48]   CHARACTERIZATION OF CARBAMYL-PHOSPHATE PHOSPHATASE-ACTIVITY AND ITS POSSIBLE ROLE IN N-(PHOSPHONACETYL)-L-ASPARTATE, (PALA), TREATMENT [J].
BLACK, MJ ;
JONES, ME .
FEDERATION PROCEEDINGS, 1983, 42 (07) :1966-1966
[49]   PROPERTIES OF SINGLE-STEP MUTANTS OF SYRIAN-HAMSTER CELL-LINES RESISTANT TO N-(PHOSPHONACETYL)-L-ASPARTATE [J].
ZIEG, J ;
CLAYTON, CE ;
ARDESHIR, F ;
GIULOTTO, E ;
SWYRYD, EA ;
STARK, GR .
MOLECULAR AND CELLULAR BIOLOGY, 1983, 3 (11) :2089-2098
[50]   EFFECTS OF N-(PHOSPHONACETYL)-L-ASPARTATE ON MURINE TUMORS AND NORMAL TISSUES INVIVO AND INVITRO AND RELATIONSHIP OF SENSITIVITY TO RATE OF PROLIFERATION AND LEVEL OF ASPARTATE-TRANSCARBAMYLASE [J].
JOHNSON, RK ;
SWYRYD, EA ;
STARK, GR .
CANCER RESEARCH, 1978, 38 (02) :371-378
12345